hVIVO plc (LON:HVO – Get Free Report) crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 27.83 ($0.34) and traded as high as GBX 29 ($0.36). hVIVO shares last traded at GBX 28.50 ($0.35), with a volume of 2,635,820 shares trading hands.
hVIVO Trading Up 0.4 %
The company has a fifty day simple moving average of GBX 27.83 and a two-hundred day simple moving average of GBX 24.46. The company has a debt-to-equity ratio of 9.83, a current ratio of 1.46 and a quick ratio of 1.16. The company has a market capitalization of £194.65 million, a P/E ratio of -1.00 and a beta of 0.99.
hVIVO Cuts Dividend
The business also recently announced a dividend, which will be paid on Monday, May 20th. Shareholders of record on Thursday, April 18th will be issued a dividend of GBX 0.20 ($0.00) per share. The ex-dividend date is Thursday, April 18th. This represents a yield of 0.68%.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Read More
- Five stocks we like better than hVIVO
- Using the MarketBeat Dividend Yield Calculator
- High-Yield Texas Instruments Could Hit New Highs Soon
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Investing In Automotive Stocks
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
